117 related articles for article (PubMed ID: 2435020)
1. LAV/HTLV-III antibodies in patients treated with intravenous gammaglobulins.
Kanoh T; Ohno T; Funakoshi N; Fujii H; Okada T
Tohoku J Exp Med; 1986 Nov; 150(3):361-2. PubMed ID: 2435020
[TBL] [Abstract][Full Text] [Related]
2. Testing for antibodies to AIDS-associated retrovirus (HTLV-III/LAV) by indirect fixed cell immunofluorescence: specificity, sensitivity, and applications.
Hedenskog M; Dewhurst S; Ludvigsen C; Sinangil F; Rodriguez L; Wu YT; Volsky DJ
J Med Virol; 1986 Aug; 19(4):325-34. PubMed ID: 3018138
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of two ELISA kits for the demonstration of antibodies against LAV/HTLV-III].
Heinz FX; Kunz C; Barrett N
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):196-200. PubMed ID: 3307232
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and specificity of commercial ELISA kits for screening anti-LAV/HTLV III.
Gürtler LG; Eberle J; Lorbeer B; Deinhardt F
J Virol Methods; 1987 Jan; 15(1):11-23. PubMed ID: 3468119
[TBL] [Abstract][Full Text] [Related]
5. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
[TBL] [Abstract][Full Text] [Related]
6. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China.
Zeng Y; Fan J; Zhang Q; Wang PC; Tang DJ; Zhon SC; Zheng XW; Liu DP
AIDS Res; 1986 Dec; 2 Suppl 1():S147-9. PubMed ID: 3103638
[TBL] [Abstract][Full Text] [Related]
7. [HIV (HTLV III/LAV) serology: experiences based on more than 42,000 tests].
Gschnait F; Schmidt BL; Schwarz T; Heinz FX; Kunz C
Wien Klin Wochenschr; 1987 Aug; 99(15):536-9. PubMed ID: 3310415
[TBL] [Abstract][Full Text] [Related]
8. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits.
Abb J
AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224
[TBL] [Abstract][Full Text] [Related]
9. Search for HTLV-I and LAV/HTLV-III antibodies in serum and CSF of multiple sclerosis patients.
De Rossi A; Gallo P; Tavolato B; Callegaro L; Chieco-Bianchi L
Acta Neurol Scand; 1986 Aug; 74(2):161-4. PubMed ID: 3022528
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of serological cross-reactivity between antibodies to Plasmodium and HTLV-III/LAV.
Greenberg AE; Schable CA; Sulzer AJ; Collins WE; Phuc Nguyen-Dinh
Lancet; 1986 Aug; 2(8501):247-9. PubMed ID: 2874279
[TBL] [Abstract][Full Text] [Related]
11. Western blot technique in the serological evaluation of three LAV/HTLV III-infected Italian families.
Geroldi D; Aricò M; Plebani A; Maccario R; Notarangelo LD; Duse M; Rey F; Barrè Sinoussi F; Chermann JC; Burgio GR
Infection; 1986; 14(2):60-3. PubMed ID: 3011677
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to AIDS-associated retrovirus (HTLV-III/LAV) in drug addicts from Vizcaya, northern Spain.
Merino F; Esparza B; Aizpiri J; Fernandez J; de Masdelval L; Arrieta A; Velazquez M; Volsky DJ; San Cristobal E; de Izaguirre A
AIDS Res; 1986; 2(2):133-40. PubMed ID: 3013221
[TBL] [Abstract][Full Text] [Related]
13. [HIV-antibodies in cord blood samples from Uganda].
Müller HA; Marquart KH; Hartter P
Immun Infekt; 1987 Jul; 15(4):146-8. PubMed ID: 3114131
[TBL] [Abstract][Full Text] [Related]
14. Enzyme immunoassays for the demonstration of antibodies to HIV-2SBL-6669 and HTLV-IV (SIVmac).
Biberfeld G; Thorstensson R; Bergström M; Naucler A; Costa CM
AIDS; 1988 Jun; 2(3):195-9. PubMed ID: 3134913
[TBL] [Abstract][Full Text] [Related]
15. [Detection of antibodies to HTLV-III: a comparison of various ELISA methods as screening tests and the Western Blot with immunofluorescence as confirmatory procedures].
Hengster P; Larcher C; Pöckl E; Schulz T; Wachter H; Dierich MP
Wien Klin Wochenschr; 1987 Feb; 99(4):112-4. PubMed ID: 3554776
[TBL] [Abstract][Full Text] [Related]
16. Screening and confirmatory tests for antibody to HTLV-III/LAV retrovirus in individuals at risk for AIDS.
De Majo E; Ravina A; Ricciarelli L; Parri F; Mazzetti M; Di Pietro M; Colao MG; Milo D; Romagnani S
Ric Clin Lab; 1986; 16(3):489-94. PubMed ID: 3544160
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to human immunodeficiency virus (HTLV-III/LAV) in people from Lagos and Cross River States of Nigeria.
Okpara RA; Akinsete I; Williams EE; Schneider J; Wendler I; Hunsmann G
Acta Haematol; 1988; 79(2):91-3. PubMed ID: 3124480
[TBL] [Abstract][Full Text] [Related]
18. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
19. Comparison between enzyme-linked immunosorbent and I.F. assays in the serological diagnosis of HIV infections.
Borghi V; De Palma M; Vecchi M; Pellegrino F; Mongiardo N; Cocchi I; De Rienzo B; Squadrini F
Microbiologica; 1988 Jan; 11(1):81-4. PubMed ID: 3280951
[TBL] [Abstract][Full Text] [Related]
20. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)].
Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G
Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290
[No Abstract] [Full Text] [Related]
[Next] [New Search]
